Off‐label underdosing of four individual <scp>NOACs</scp> in patients with nonvalvular atrial fibrillation: A systematic review and meta‐analysis of observational studies-Reference-Cited by-同舟云学术

Off‐label underdosing of four individual NOACs in patients with nonvalvular atrial fibrillation: A systematic review and meta‐analysis of observational studies

Published:2022-06-06 Issue:10 Volume:52 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Investigation

Author:

Sang Chuanlan¹,Chen Jiming²,Sun Junyi²,Lai Yuhui²,Liu Xiao³,Zhu Wengen²^ORCID

Affiliation:

1. Animal Experiment Center Guangzhou University of Chinese Medicine Guangzhou China

2. Department of Cardiology The First Affiliated Hospital of Sun Yat‐Sen University Guangzhou China

3. Department of Cardiology Sun Yat‐sen Memorial Hospital of Sun Yat‐sen University Guangzhou China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13819

Reference32 articles.

1. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

2. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons

3. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

4. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

5. Apixaban versus Warfarin in Patients with Atrial Fibrillation

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A real-world study of different doses of rivaroxaban in patients with nonvalvular atrial fibrillation;Medicine;2024-04-26

2. Effect of Direct Oral Anticoagulants in Patients with Splanchnic Vein Thrombosis: A Systematic Reviews and Meta-Analysis;Clinical and Applied Thrombosis/Hemostasis;2024-01

3. Prevalence, contemporary trends and associated factors of potentially inappropriate prescription of edoxaban in real‐world clinical practice: A subanalysis of the SUNSHINE registry;British Journal of Clinical Pharmacology;2023-12-13

4. Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies;Europace;2023-09-20

5. Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes;Annals of Pharmacotherapy;2023-09-15